Skip to main content

Medtronic will sell Intersect ENT subsidiary Fiagon to Hemostasis to win FTC approval of acquisition

Medtronic must divest part of a California-based medical device company it plans to acquire if it wants approval of the deal, the Federal Trade Commission said this week.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.